| European Case Law Identifier: | ECLI:EP:BA:2017:T125511.20171129 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 29 November 2017 | ||||||||
| Case number: | T 1255/11 | ||||||||
| Application number: | 01930965.7 | ||||||||
| IPC class: | A61K 31/215 A61K 31/19 A61K 31/205 A61P 25/28 |
||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | D | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | USE OF MEDIUM CHAIN TRIGLYCERIDES FOR THE TREATMENT AND PREVENTION OF ALZHEIMER'S DISEASE | ||||||||
| Applicant name: | Accera, Inc. | ||||||||
| Opponent name: | Lupton, Frederick | ||||||||
| Board: | 3.3.01 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: |
|
||||||||
| Keywords: | Amendments - allowable (yes) Sufficiency of disclosure - (yes) Remittal to the department of first instance - (yes) |
||||||||
| Catchwords: |
- |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t111255eu1.html
Date retrieved: 17 May 2021